IL-17A inhibitor-induced leucocytoclastic vasculitis is responsive to IL-23 blockade in a psoriatic arthritis patient.

Authors :: Binod KC
Jabbour A
Poudel P
Banki K
Perl A
Source :: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Jan 11; Vol. 83 (2), pp. 265-267. Date of Electronic Publication: 2024 Jan 11.
Publication Year :: 2024
Abstract: Competing Interests: Competing interests: None declared.

Subjects :: Humans
Interleukin-17
Antibodies, Monoclonal, Humanized pharmacology
Interleukin-23
Arthritis, Psoriatic drug therapy
Vasculitis, Leukocytoclastic, Cutaneous chemically induced
Psoriasis

Full Text Access

Tools